Jose Rey, MD
Family Medicine · Hialeah, FLNPI 1194749515
Payments from drug & device makers
Across 28 payments — averaging $91.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Amgen$97
- Gilead$41
- Teva Pharmaceuticals USA, Inc.$39
- E.r. Squibb & Sons, L.L.C.$39
- KARL Storz Endoscopy-america$35
- plus $63 from 4 others
What the payments were for
- Speaking & faculty fees$1,30051%
- Travel & lodging$76730%
- Food & beverage$50019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 13 | $2,252 |
| Amgen | 6 | $97 |
| Gilead | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $39 |
| E.r. Squibb & Sons, L.L.C. | 1 | $39 |
| KARL Storz Endoscopy-america | 1 | $35 |
| Exact Sciences | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$2,025
- INVEGA TRINZA$2,025
How this compares
$2,566 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,292 |
| Omega-3 Acid Ethyl Esters | 30 | $3,266 |
| Advair DiskusFluticasone Propion/Salmeterol | 11 | $2,176 |
| Gabapentin | 54 | $1,166 |
| Famotidine | 52 | $1,143 |
| Rosuvastatin Calcium | 75 | $964 |
| Azelastine Hcl | 13 | $753 |
| Diclofenac Sodium | 38 | $681 |
| Ibandronate Sodium | 14 | $604 |
| Ciclopirox | 12 | $569 |
| Omeprazole | 25 | $539 |
| Atorvastatin Calcium | 69 | $413 |
| Metformin Hcl | 101 | $391 |
| Tamsulosin Hcl | 31 | $297 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $288 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Hialeah
- Dario AltamiranoHialeah$15.5M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.